Jerome Benedict Durso, President and CEO of Altimmune, Inc. (NASDAQ:ALT), filed a Form 4 on August 13, 2026, reporting the open-market purchase of 15,000 shares of Altimmune common stock on that same date.
Key Highlights
- Reporting person: Jerome Benedict Durso, identified as President and CEO, and as a Director of Altimmune, Inc.
- Transaction: Purchase (transaction code P) of 15,000 shares of Common Stock, par value $0.0001, on 08/13/2026.
- Price paid: $2.95 per share, according to the filing.
- Resulting ownership: Following the transaction, Durso directly beneficially owned 62,500 shares of Altimmune common stock.
- No derivative securities: Table II of the filing reports no derivative security transactions.
Altimmune CEO Durso Acquires Shares at $2.95 in August 2026 Transaction
According to the Form 4 filed with the U.S. Securities and Exchange Commission, Jerome Benedict Durso, serving as both a Director and President and CEO of Altimmune, Inc., reported a single non-derivative securities transaction dated August 13, 2026. The filing discloses the acquisition of 15,000 shares of Altimmune common stock (par value $0.0001 per share) at a price of $2.95 per share, coded as a purchase (P) under the applicable transaction coding instructions.
Following the reported transaction, the filing states that Durso directly beneficially owned 62,500 shares of Altimmune common stock. The filing indicates that ownership is held directly (D) and does not report any indirect beneficial ownership or derivative securities activity in Table II. The Form 4 was signed by Gregory Weaver as Attorney-in-Fact on behalf of Durso, also on August 13, 2026. No Rule 10b5-1 plan box was checked in connection with this transaction, and the filing was made by one reporting person.
What Was Disclosed
The filing reports that Altimmune's President and CEO purchased 15,000 shares of common stock at $2.95 per share on August 13, 2026, bringing his total direct beneficial ownership to 62,500 shares. No derivative security transactions were reported.



Please wait processing your request...